Comparison of drug-coated balloon angioplasty versus standard medical therapy on recurrent stroke and mortality rates among patients with symptomatic intracranial atherosclerotic stenosis: protocol for a systematic review and meta-analysis

被引:4
作者
Sun, Yixin [1 ,2 ,3 ]
Luo, Jichang [1 ,4 ,5 ]
Gong, Haozhi [1 ,4 ,5 ]
Xu, Ran [1 ,4 ,5 ]
Zhang, Xiao [1 ,4 ,5 ]
Yang, Bin [1 ,4 ,5 ]
Ma, Yan [1 ,4 ,5 ]
Wang, Tao [1 ,4 ,5 ]
Jiao, Liqun [1 ,4 ,5 ,6 ]
机构
[1] Capital Med Univ, Dept Neurosurg, Xuanwu Hosp, Beijing, Peoples R China
[2] Peking Univ First Hosp, Beijing, Peoples R China
[3] Peking Univ, Hlth Sci Ctr, Beijing, Peoples R China
[4] China Int Neurosci Inst, Beijing, Peoples R China
[5] Natl Ctr Neurol Disorders, Beijing, Peoples R China
[6] Capital Med Univ, Dept Intervent Neuroradiol, Xuanwu Hosp, Beijing, Peoples R China
关键词
NEUROSURGERY; Systematic Review; Interventional radiology; STROKE MEDICINE; Stroke; TRANSIENT ISCHEMIC ATTACK; STENT; RISK; PREVALENCE; CHINA;
D O I
10.1136/bmjopen-2023-078040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Stroke remains the second leading cause of death worldwide, a common cause of which is intracranial atherosclerotic stenosis (ICAS). Medical treatment is recommended as first-line therapy for treating ICAS, but the recurrence rate remains high. Drug-coated balloon (DCB) angioplasty has been designed to lower the risk of recurrent stenosis, holding therapeutic promise in the treatment of ICAS. However, the benefits of DCB require further evaluation. Methods and analysis The Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols was followed to develop this protocol. We will systematically search online databases including Cochrane Central Register of Controlled Trials, PubMed, Web of Science, EMBASE, China Biological Medicine Database, ClinicalTrials.gov and WHO ICTRP from 1 January 2011 to the date of search. This will be supplemented by a manual search of unpublished and ongoing trials to manually select articles for inclusion. Inclusion criteria are randomised or quasi-randomised clinical trials and observational studies that investigated DCB or medical treatment for patients with a symptomatic ICAS of 50%-99%. The primary outcome is short-term composite safety including death of any cause, or non-fatal stroke. Secondary outcomes include long-term death or stroke, restenosis, neurological rehabilitation, quality of life and other complications. The available data will be analysed using meta-analysis, if appropriate. The evaluation of heterogeneity and biases will be guided by the Cochrane Handbook for Systematic Reviews of Interventions. Ethics and dissemination This systematic review does not require ethical approval as all available data from eligible studies will be anonymous with no concerns regarding privacy. Our findings will be disseminated through international conferences and peer-reviewed publications. Additional data from the study are available on request to corresponding authors via email.
引用
收藏
页数:8
相关论文
共 53 条
[11]   Device profile of different paclitaxel-coated balloons: Neuro Elutax SV, Elutax '3' Neuro and SeQuent Please NEO for the treatment of symptomatic intracranial high-grade stenosis: overview of their feasibility and safety [J].
Gruber, Philipp ;
Remonda, Luca .
EXPERT REVIEW OF MEDICAL DEVICES, 2020, 17 (02) :87-92
[12]   Percutaneous transluminal angioplasty using the novel drug-coated balloon catheter SeQuent Please NEO for the treatment of symptomatic intracranial severe stenosis: feasibility and safety study [J].
Gruber, Philipp ;
Braun, Christina ;
Kahles, Timo ;
Hlavica, Martin ;
Anon, Javier ;
Diepers, Michael ;
Nedeltchev, Krassen ;
Berberat, Jatta ;
Remonda, Luca .
JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2019, 11 (07) :719-+
[13]   Neuro Elutax SV drug-eluting balloon versus Wingspan stent system in symptomatic intracranial high-grade stenosis: a single-center experience [J].
Gruber, Philipp ;
Garcia-Esperon, Carlos ;
Berberat, Jatta ;
Kahles, Timo ;
Hlavica, Martin ;
Anon, Javier ;
Diepers, Michael ;
Nedeltchev, Krassen ;
Remonda, Luca .
JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2018, 10 (12) :E32-+
[14]  
Gutierrez J, 2022, LANCET NEUROL, V21, P355, DOI 10.1016/S1474-4422(21)00376-8
[15]   GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables [J].
Guyatt, Gordon ;
Oxman, Andrew D. ;
Akl, Elie A. ;
Kunz, Regina ;
Vist, Gunn ;
Brozek, Jan ;
Norris, Susan ;
Falck-Ytter, Yngve ;
Glasziou, Paul ;
deBeer, Hans ;
Jaeschke, Roman ;
Rind, David ;
Meerpohl, Joerg ;
Dahm, Philipp ;
Schuenemann, Holger J. .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2011, 64 (04) :383-394
[16]   Intracranial Atherosclerosis Is Associated with Progression of Neurological Deficit in Subcortical Stroke [J].
Hallevi, Hen ;
Chernyshev, Oleg Y. ;
El Khoury, Ramy ;
Soileau, Michael J. ;
Walker, Kyle C. ;
Grotta, James C. ;
Savitz, Sean I. .
CEREBROVASCULAR DISEASES, 2012, 33 (01) :64-68
[17]   Drug-coated balloons for the treatment of symptomatic intracranial atherosclerosis: initial experience and follow-up outcome [J].
Han, Ju ;
Zhang, Jun ;
Zhang, Xiao ;
Zhang, Jinping ;
Song, Yun ;
Zhao, Wei ;
Zheng, Meimei ;
Sun, Lili ;
Wang, Wei .
JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2019, 11 (06) :569-573
[18]   Stroke [J].
Hankey, Graeme J. .
LANCET, 2017, 389 (10069) :641-654
[19]   Measuring inconsistency in meta-analyses [J].
Higgins, JPT ;
Thompson, SG ;
Deeks, JJ ;
Altman, DG .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7414) :557-560
[20]   Prevalence, predictors, and prognosis of symptomatic intracranial stenosis in patients with transient ischaemic attack or minor stroke: a population-based cohort study [J].
Hurford, Robert ;
Wolters, Frank J. ;
Li, Linxin ;
Lau, Kui Kai ;
Kuker, Wilhelm ;
Rothwell, Peter M. .
LANCET NEUROLOGY, 2020, 19 (05) :413-421